合計 50 件の最近のインサイダー取引記録が記録されています Reneo Pharmaceuticals, Inc. (RPHM), 内訳は 40 件の買い および 6 件の売り. インサイダー買い総額は $3.98M インサイダー売り総額は $1.5M.
最近活動のある主要インサイダーには Leonard Braden Michael, Hall Ashley, Grey Michael G. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — RPHM
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2024-09-25 |
Leonard Braden Michael |
10 Percent Owner |
情報に基づく買い |
68,746 |
$1.50 |
$102.87K |
3,457,395 |
| 2024-09-24 |
Leonard Braden Michael |
10 Percent Owner |
情報に基づく買い |
29,600 |
$1.41 |
$41.87K |
3,388,649 |
| 2024-09-18 |
Leonard Braden Michael |
10 Percent Owner |
情報に基づく買い |
806 |
$1.40 |
$1.13K |
3,359,049 |
| 2024-09-17 |
Leonard Braden Michael |
10 Percent Owner |
情報に基づく買い |
55,300 |
$1.36 |
$75.11K |
3,358,243 |
| 2024-09-16 |
Leonard Braden Michael |
10 Percent Owner |
情報に基づく買い |
172,747 |
$1.37 |
$236.87K |
3,302,943 |
| 2024-09-13 |
Leonard Braden Michael |
10 Percent Owner |
情報に基づく買い |
150,000 |
$1.31 |
$196.95K |
3,130,196 |
| 2024-09-12 |
Leonard Braden Michael |
10 Percent Owner |
情報に基づく買い |
36,176 |
$1.40 |
$50.52K |
2,980,196 |
| 2024-08-14 |
Leonard Braden Michael |
10 Percent Owner |
情報に基づく買い |
100,487 |
$1.41 |
$142.01K |
2,944,020 |
| 2024-08-13 |
Leonard Braden Michael |
10 Percent Owner |
情報に基づく買い |
171,339 |
$1.39 |
$238.59K |
2,843,533 |
| 2024-05-14 |
Leonard Braden Michael |
10 Percent Owner |
処分 |
- |
- |
- |
1,020,769 |
| 2024-05-14 |
Leonard Braden Michael |
10 Percent Owner |
情報に基づく買い |
79,281 |
$1.56 |
$123.68K |
2,337,194 |
| 2023-08-28 |
Hall Ashley |
Chief Development Officer |
情報に基づく売り |
15,625 |
$6.28 |
$98.06K |
39,600 |
| 2023-07-26 |
Grey Michael G |
Executive Chairman |
贈与(送付) |
50,000 |
- |
- |
- |
| 2023-06-23 |
Novo Holdings A/s |
10 Percent Owner |
情報に基づく売り |
100,000 |
$7.10 |
$709.74K |
3,330,337 |
| 2023-06-06 |
Grey Michael G |
Executive Chairman |
RSU 付与(制限付株式) |
17,500 |
$9.01 |
$157.68K |
17,500 |
| 2023-06-06 |
Mathers Edward T |
Director |
RSU 返還(制限付株式) |
17,500 |
$9.01 |
$157.68K |
17,500 |
| 2023-06-06 |
Hoelscher Paul W. |
Director |
RSU 付与(制限付株式) |
17,500 |
$9.01 |
$157.68K |
17,500 |
| 2023-06-06 |
Seltzer Stacey Denenberg |
Director |
RSU 付与(制限付株式) |
17,500 |
$9.01 |
$157.68K |
17,500 |
| 2023-06-06 |
Dube Eric M |
Director |
RSU 付与(制限付株式) |
17,500 |
$9.01 |
$157.68K |
17,500 |
| 2023-06-06 |
O'donnell Niall |
Director |
RSU 付与(制限付株式) |
17,500 |
$9.01 |
$157.68K |
17,500 |
| 2023-06-06 |
Muralidhar Bali |
Director |
RSU 付与(制限付株式) |
17,500 |
$9.01 |
$157.68K |
17,500 |
| 2023-06-06 |
Blunt Roshawn A. |
Director |
RSU 付与(制限付株式) |
14,815 |
$9.01 |
$133.48K |
14,815 |
| 2023-05-08 |
O'donnell Niall |
Director |
情報に基づく買い |
125,000 |
$8.00 |
$1M |
2,188,713 |
| 2022-12-09 |
Dorenbaum Alejandro |
Chief Medical Officer |
RSU 付与(制限付株式) |
125,000 |
- |
- |
125,000 |
| 2022-12-09 |
Flesher Gregory J. |
President and CEO |
RSU 付与(制限付株式) |
300,000 |
- |
- |
300,000 |
| 2022-12-09 |
Hall Ashley |
Chief Development Officer |
RSU 付与(制限付株式) |
125,000 |
- |
- |
125,000 |
| 2022-12-09 |
Cruse Michael |
Chief Operating Officer |
RSU 付与(制限付株式) |
125,000 |
- |
- |
125,000 |
| 2022-12-09 |
Lam Jennifer |
VP of Finance & Administration |
RSU 付与(制限付株式) |
90,000 |
- |
- |
90,000 |
| 2022-09-01 |
Cruse Michael |
Chief Operating Officer |
情報に基づく買い |
7,500 |
$3.39 |
$25.45K |
13,697 |
| 2022-08-31 |
Grey Michael G |
Executive Chairman |
オプション行使 |
50,000 |
$1.97 |
$98.5K |
50,000 |
| 2022-08-29 |
Cruse Michael |
Chief Operating Officer |
情報に基づく買い |
3,212 |
$3.21 |
$10.31K |
6,197 |
| 2022-08-12 |
Dorenbaum Alejandro |
Chief Medical Officer |
贈与(送付) |
22,348 |
- |
- |
30,000 |
| 2022-08-02 |
Blunt Roshawn A. |
Director |
不明 |
- |
- |
- |
- |
| 2022-08-02 |
Blunt Roshawn A. |
Director |
RSU 付与(制限付株式) |
35,000 |
$2.80 |
$98K |
35,000 |
| 2022-06-01 |
Grey Michael G |
Executive Chairman |
RSU 付与(制限付株式) |
17,500 |
$2.09 |
$36.58K |
17,500 |
| 2022-06-01 |
Mathers Edward T |
Director |
RSU 付与(制限付株式) |
17,500 |
$2.09 |
$36.58K |
17,500 |
| 2022-06-01 |
Hoelscher Paul W. |
Director |
RSU 付与(制限付株式) |
6,376 |
- |
- |
6,376 |
| 2022-06-01 |
Seltzer Stacey Denenberg |
Director |
RSU 付与(制限付株式) |
17,500 |
$2.09 |
$36.58K |
17,500 |
| 2022-06-01 |
Dube Eric M |
Director |
RSU 付与(制限付株式) |
17,500 |
$2.09 |
$36.58K |
17,500 |
| 2022-06-01 |
O'donnell Niall |
Director |
RSU 付与(制限付株式) |
17,500 |
- |
- |
17,500 |
| 2022-06-01 |
Muralidhar Bali |
Director |
RSU 付与(制限付株式) |
17,500 |
$2.09 |
$36.58K |
17,500 |
| 2022-03-31 |
Lam Jennifer |
VP of Finance & Administration |
処分 |
10,000 |
$4.58 |
$45.8K |
- |
| 2022-03-02 |
Cruse Michael |
Chief Operating Officer |
RSU 付与(制限付株式) |
25,000 |
- |
- |
25,000 |
| 2022-01-20 |
Hoelscher Paul W. |
Director |
不明 |
- |
- |
- |
- |
| 2022-01-20 |
Hoelscher Paul W. |
Director |
RSU 付与(制限付株式) |
35,000 |
$8.01 |
$280.35K |
35,000 |
| 2021-12-10 |
Dorenbaum Alejandro |
Chief Medical Officer |
RSU 付与(制限付株式) |
30,000 |
- |
- |
52,348 |
| 2021-12-10 |
Flesher Gregory J. |
President and CEO |
RSU 付与(制限付株式) |
100,000 |
- |
- |
109,600 |
| 2021-12-10 |
Cruse Michael |
Senior VP-corporate Operations |
RSU 付与(制限付株式) |
25,000 |
- |
- |
29,100 |
| 2021-12-10 |
Jindal Vineet R. |
Chief Financial Officer |
RSU 付与(制限付株式) |
30,000 |
- |
- |
36,600 |
| 2021-12-09 |
Grey Michael G |
Executive Chairman |
処分 |
100,563 |
$4.88 |
$490.75K |
- |
■ 情報付き — 公開市場取引(最も重要)
■ 情報なし(買い) — 報酬・オプション行使・転換
■ 情報なし(売り) — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効